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histologist's report and the immunologist's
functional finding. This is a mammoth task
when one realises that there were over 1500
references to be reviewed in the 1977 litera-
ture alone. It is not surprising, therefore, that
in this, his 3rd annual review, Clive Taylor
has invited other workers from the University
of California to assist.
The subject matter covers a wide range of
conditions which may be considered to fall
under the general heading of malignant
lymphoma, including lymphocytic leukaemias
and myeloma. The first third of the review
deals with surface marker, ultrastructure,
cytochemistry, genetic and kinetic studies of
lymphoid malignancies. The rest ofthe review
deals in detail with the pathological and
clinical aspects ofthe different disease groups.
The authors are to be congratulated that the
subjects are dealt with in a clear, easily read-
able style rather than a simple list of refer-
ences. Despite the high quality of the re-
viewers, after reading the chapter on the
pathologic classification of non-Hodgkin's
lymphoma, I felt that the quote of R. Willis
(1948) which opened Chapter 1 was still true:
"Nowhere in pathology has a chaos ofnames
so clouded clear concepts as in the subject of
lymphoid tumours".
Research workers and clinicians alike will
find this a valuable review of a difficult
subject.
J. H. SCARFFE
Breast Cancer. Advances in Research and
Treatment. Vol. 3-Current Topics.
Ed. W. L. McGUIRE (1979) New York:
Plenum Publishing Corp. 271pp. $39 50.
This is the third book in this series covering
all aspects of breast cancer; its subtitle
"Current Topics" aptly describes the range
ofcontributions to the book, and the chapters
are all written by experts in their particular
field. The authors give lucid evaluations ofthe
present state ofresearch intothebasic biology
of breast cancer and into modem techniques
ofassessment and treatment ofthe disease.
There are chapters on the factors in-
fluencing metastasis and on mechanisms of
tumour regression. Much attention is paid to
the effect of the hormone environment on the
natural history of the disease, in both males
and females. All are intriguing, as they pose
as many questions as they answer and they
pin-point avenues of future research.
The position of steroid-receptor analysis in
the assessment of breast cancer is well estab-
lished, and the chapter by the editor of this
book, Bill McGuire and his co-worker Gary
Chamness, gives a clear summary ofthe assay
methods available, and some of the pitfalls
that may be encountered by newcomers to
the field.
There is an interesting chapter on mam-
mography which summarizes the recent re-
ports on the risks and benefits from the pro-
cedure, and the author emphasizes the factors
that should be considered before launching
into screening programmes.
The real value of the book is that it has
been written by people actively involved in
their particular area of breast-cancer re-
search. Each author gives a comprehensive
literature survey and builds on that back-
ground to highlight the direction in which
they think that research should proceed in
the future.
D. BARNES
Carcinogenic Risks: Strategies for Inter-
vention. Proceedings of a Symposium
organised by IARC and l'Institut National
de la Sante et de le Recherche Medicale,
1979. Ed. W. DAVIES (1979) WHO.
283 pp. 50 Sw. Fr.
The object of the symposium was to high-
light experiences and problems in this subject
area which spans scientific, legislative and
public opinions. The reader is spared a
detailed description of legislative actions in
various countries, although sufficient infor-
mation is provided to give a flavour of the
legislative approach in France, Finland,
Sweden, the U.K. and U.S.A.
The proceedings of the symposium consist
of 25 papers organized into an introduction,
5 sections and a summing up, with each
section carrying a discussion summary. The
5 sections, on smoking, occupational risks,
food additives, drugs and pesticides, measure-
ment of carcinogenic risk and strategies of
intervention, use some of the problems and
paradoxes in the control of carcinogenic risks
to illustrate its complexity. A welcome
feature is the attempt by some speakers to
identify the role of scientists as those re-
sponsible for providing data which should be672 BOOK REVIEWS
common to all countries, and the role of
legislators and the public in providing
judgments of how to control risks to an
acceptable level in a particular community.
In the first section, on smoking, the tech-
niques required to influence public opinion
and reduce the risk ofsmoking in France and
Finland are outlined. Although it is generally
accepted that the public should have a major
say in deciding the acceptability of risks, the
paradox presented by a government deciding
to legislate on smoking and then attempting
to influence public opinion to support it is not
tackled.
The international repercussions of legisla-
tion in this field are well illustrated by the
chapter on control of aflatoxin. The close
control imposed by importing countries on
aflatoxin in peanuts has a dramatic effect on
the economy and health of those whose
country depends on peanut production. The
interval between suspicion of a carcinogenic
risk and final control ofexposure can be very
long, as is illustrated by examples ofasbestos,
2-naphthylamine and vinyl chloride. The
problems of thresholds in carcinogenesis and
of comparison between chemical carcinogens
and radiation are also discussed.
Ifthe reader is expecting clear indications
of how to proceed in legislative or practical
control strategies, he will be disappointed,
because clarity is not yet present. To the
anglophile, the pragmatic but effective con-
trol of occupational exposure by the UK
government is heartening. The highlight of
the conference is in the well-balanced and
objective contribution by Dr Higginson in
the introduction, and Professor Doll in the
summing-up. To those interested in the field,
an incentive to read this volume comes from
2 quotatioqi from Higginson:
"It should not be forgotten that complex
biological processes are not basically altered
by legislation or legal definition, however
rational", and "I do not believe that the
cause of cancer prevention is served by
acrimonious adversary tactics and attempts
to denigrate the integrity of colleagues."
In general it is an interesting, if somewhat
superficial, look at the problems posed by
legislation and control of carcinogens. It will
be ofparticular value to scientists who do not
normally work in this field, because it gives
them an insight into the complexity of the
issues which have to be tackled.
I. F. H. PURCHASE
Tumor Associated Antigens and Their
Specific Immune Response. Eds F.
SPREAFICO and R. ARNON (1979). London:
Academic Press. 359 pp. £15.00, $31.00.
This book presents the proceedings of a
meeting in Milan in the summer of 1977 and
covers a wide range of topics in tumour
immunology. The list of contributors is im-
pressive, and several of the papers presented
give a valuable review of work in progress
in different laboratories. The major themes
discussed are antigen expression on virally
and chemically induced tumours (Comoglio,
Baldwin, Parmiani); activation of T-cell
cytotoxic mechanisms (Berke, Alexander,
Collavo, Keder, Scherter); natural immunity
against animal and human tumours (Herber-
man, Haller, Forni, Della Porta) and studies
ofantigen expression and immunocompetence
in cancer patients (Thompson, Adler, Stein).
Consideration is also given to the effects of
drug treatments on antigenicity and immuno-
competence in animals (Mantovani, Bon-
massar) and to the possible use of xenoan-
tisera in therapy (Arnon and Davies).
The book offers an attractive collection of
papers on major areas in tumour immunity
by recognized authorities. The papers are
generally critical and seek to subject the field
to the close scrutiny that is necessary if it is
to flourish. The extensive reference lists of
each contribution are also useful. This book
is to be recommended, though it is probable
that all the papers have now appeared in the
journal literature, as might be expected 2
years after the conference. To have them
combined in this form is a realistic addition
to any worker's bookshelf.
B. M. VOSE
Atlas of Clinical Cytology. P. LOPES
CARDOZO (1979). The Netherlands: Heine-
mann. 732 pp. £75.00.
This is an unusual book in that it presents
the accumulated experience of one man over
a period of more than 25 years. In the first
chapter Dr Lopes Cardozo states his basic
philosophy of clinical cytology, detailing the
diagnostic range of cytological techniques;
this would be useful reading for clinicians as
well as cytologists. The second chapter, on
criteria of malignancy, needs careful study to
appreciate the remainder of the atlas, par-